Francesca Petralia

10.0k total citations · 1 hit paper
28 papers, 591 citations indexed

About

Francesca Petralia is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Francesca Petralia has authored 28 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 10 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Francesca Petralia's work include Inflammatory Bowel Disease (13 papers), Microscopic Colitis (7 papers) and Bioinformatics and Genomic Networks (6 papers). Francesca Petralia is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Microscopic Colitis (7 papers) and Bioinformatics and Genomic Networks (6 papers). Francesca Petralia collaborates with scholars based in United States, Portugal and Austria. Francesca Petralia's co-authors include Pei Wang, Jean‐Frédéric Colombel, Zhidong Tu, Jialiang Yang, Manasi Agrawal, Tine Jess, Kristine H. Allin, Joana Torres, Fred Princen and Mark S. Riddle and has published in prestigious journals such as Bioinformatics, Gastroenterology and Cancer Research.

In The Last Decade

Francesca Petralia

23 papers receiving 587 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiomics to elucidate inflammatory bowel disease risk factors and pathways

2022 127 citations Manasi Agrawal, Kristine H. Allin et al. Nature Reviews Gastroenterology & Hepatology profile →

Peers

Countries citing papers authored by Francesca Petralia

Since Specialization

Citations

This map shows the geographic impact of Francesca Petralia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Petralia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Petralia more than expected).

Fields of papers citing papers by Francesca Petralia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Petralia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Petralia. The network helps show where Francesca Petralia may publish in the future.

Co-authorship network of co-authors of Francesca Petralia

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Petralia. A scholar is included among the top collaborators of Francesca Petralia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Petralia. Francesca Petralia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disease duration impacts intestinal gene expression profiles in Crohn’s disease but not in ulcerative colitis 2025 ·Journal of Crohn s and Colitis ·(unknown), (unknown), Bernhard Y. Renard, Louis Cohen, Carmen Argmann, Drew Helmus, Eric E. Schadt, Miriam Mérad, A. K. Kukreja, Sudha Visvanathan, Bruce E. Sands, Marla C. Dubinsky, Mayte Suárez‐Fariñas, Jean‐Frédéric Colombel, Erwin P. Böttinger, Judy H. Cho, Francesca Petralia, Ryan C. Ungaro	0
2	Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trial 2025 ·Contemporary Clinical Trials ·(unknown), Ryan C. Ungaro, Ayanna Lewis, (unknown), (unknown), (unknown), (unknown), Saurabh Mehandru, Francesca Petralia, Jean‐Frédéric Colombel	0
3	OP01 Systemic antibody responses predict the onset of Inflammatory Bowel Disease up to 10 years before diagnosis 2025 ·Journal of Crohn s and Colitis ·Arno R. Bourgonje, Giuseppe Pietro Innocenti, Alexandra E. Livanos, (unknown), (unknown), Mark S. Riddle, Renée M. Laird, Thierry Dervieux, Chad K. Porter, Sacha Gnjatic, Francesca Petralia, Joana Torres, Mayte Suárez‐Fariñas, Thomas Vogl, Jean‐Frédéric Colombel, Saurabh Mehandru	0
4	Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry 2024 ·Clinical Gastroenterology and Hepatology ·Steven H. Itzkowitz, Yue Jiang, Cristina Villagra, Jean‐Frédéric Colombel, (unknown), Dana J. Lukin, David M. Faleck, Ellen Scherl, Shannon Chang, Lea Ann Chen, Seymour Katz, (unknown), Arun Swaminath, Francesca Petralia, (unknown), David B. Sachar, Lina Jandorf, Jordan E. Axelrad	5
5	Anti-integrin αvβ6 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity 2024 ·Clinical Gastroenterology and Hepatology ·(unknown), Alexandra E. Livanos, (unknown), Richard E. Dean, (unknown), Arno R. Bourgonje, Michael Tankelevich, (unknown), Judy H. Cho, (unknown), Cecília M. P. Rodrigues, Francesca Petralia, Jean‐Frédéric Colombel, Christopher L. Bowlus, Thomas D. Schiano, Joana Torres, Cynthia Levy, Saurabh Mehandru	0
6	OP39 Vedolizumab response in ulcerative colitis associates with reduced IgG+ plasma cells and FcγR signaling 2024 ·Journal of Crohn s and Colitis ·Pablo Canales-Herrerías, Mathieu Uzzan, (unknown), Akihiro Seki, Bram Verstockt, Alexandra E. Livanos, Michael Tankelevich, (unknown), Francesca Cossarini, Divya Jha, Michael D. Taylor, Adam Rosenstein, Andrea Cerutti, Francesca Petralia, Carmen Argmann, Mayte Suárez‐Fariñas, Alexandros D. Polydorides, J F Colombel, Saurabh Mehandru	0
7	Decomprolute is a benchmarking platform designed for multiomics-based tumor deconvolution 2024 ·Cell Reports Methods ·Song Feng, Anna Calinawan, Pietro Pugliese, Pei Wang, Michele Ceccarelli, Francesca Petralia, Sara J.C. Gosline	2
8	Preclinical Serological Signatures are Associated With Complicated Crohn’s Disease Phenotype at Diagnosis 2023 ·Clinical Gastroenterology and Hepatology ·Rok Seon Choung, Francesca Petralia, Joana Torres, Ryan C. Ungaro, (unknown), Takahiro Sato, Shannon Telesco, Richard Strauß, Scott E. Plevy, Fred Princen, Mark S. Riddle, Joseph A. Murray, Jean‐Frédéric Colombel	14
9	Multiomics to elucidate inflammatory bowel disease risk factors and pathways breakdown → 2022 ·Nature Reviews Gastroenterology & Hepatology ·Manasi Agrawal, Kristine H. Allin, Francesca Petralia, Jean‐Frédéric Colombel, Tine Jess	127
10	Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials 2022 ·Inflammatory Bowel Diseases ·Manasi Agrawal, Francesca Petralia, (unknown), (unknown), Walter Reinisch, Jean‐Frédéric Colombel, Shailja C. Shah	12
11	Abstract 2170: Proteogenomic and metabolomic characterization of human glioblastoma 2021 ·Cancer Research ·Liang-Bo Wang, Alla Karpova, Marina Gritsenko, Jennifer Kyle, Song Cao, Yize Li, Dmitry Rykunov, Antonio Colaprico, Joseph H. Rothstein, Runyu Hong, Vasileios Stathias, MacIntosh Cornwell, Francesca Petralia, Richard Smith, Antonio Iavarone, Milan G. Chheda, Jill S. Barnholtz‐Sloan, Karin Rodland, Tao Liu, Li Ding	1
12	P433 Sex-based differences in response to tumor necrosis factor inhibitor induction therapy for ulcerative colitis: a pooled analysis of individual patient-level clinical trials data 2021 ·Journal of Crohn s and Colitis ·Manasi Agrawal, Francesca Petralia, (unknown), (unknown), Walter Reinisch, Jean‐Frédéric Colombel, Shailja C. Shah	1
13	DOP58 Non-white race is associated with decreased efficacy of tumor necrosis factor antagonist therapy in Ulcerative Colitis: A post-hoc analysis of individual level data from golimumab clinical trials 2021 ·Journal of Crohn s and Colitis ·(unknown), Francesca Petralia, Thomas Ullman, J F Colombel, Ryan C. Ungaro	1
14	Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis 2020 ·Gastroenterology ·Joana Torres, Francesca Petralia, Takahiro Sato, Pei Wang, Shannon Telesco, Rok Seon Choung, Richard Strauß, Xiaojun Li, Renée M. Laird, Ramiro L. Gutiérrez, Chad K. Porter, Scott E. Plevy, Fred Princen, Joseph Murray, Mark S. Riddle, Jean‐Frédéric Colombel	145
15	Sa1818 – Innate Immune Dysregulation, Detectable Up to 6 Years Before the Diagnosis of Crohn's Disease, is Significantly Amplified in Patients with a Complicated Phenotype 2019 ·Gastroenterology ·Rok Seon Choung, Francesca Petralia, (unknown), Takahiro Sato, Xiaojun Li, Pei Wang, Shannon Telesco, Chad K. Porter, Renée M. Laird, Ramiro L. Gutiérrez, Fred Princen, Scott E. Plevy, Richard Strauss, Mark S. Riddle, Joseph Murray, Jean‐Frédéric Colombel	2
16	A new method to study the change of miRNA–mRNA interactions due to environmental exposures 2017 ·Bioinformatics ·Francesca Petralia, Vasily N. Aushev, Kalpana Gopalakrishnan, Maya Kappil, (unknown), Jia Chen, Susan L. Teitelbaum, Pei Wang	3
17	New Method for Joint Network Analysis Reveals Common and Different Coexpression Patterns among Genes and Proteins in Breast Cancer 2016 ·Journal of Proteome Research ·Francesca Petralia, Won‐Min Song, Zhidong Tu, Pei Wang	14
18	Integrative random forest for gene regulatory network inference 2015 ·Bioinformatics ·Francesca Petralia, Pei Wang, Jialiang Yang, Zhidong Tu	132
19	Repulsive Mixtures 2012 ·Neural Information Processing Systems ·Francesca Petralia, Vinayak Rao, David B. Dunson	3
20	Adversarial risk analysis: Borel games 2011 ·Applied Stochastic Models in Business and Industry ·David Banks, Francesca Petralia, Shouqiang Wang	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact